EBONIQUE BUCKNER: Open Payments
NPI 1003465352 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 34 payments from 5 companies in 2025. Trend: 2023 $254 · 2024 $320 · 2025 $982
Food & beverage: $913Education: $69
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $257 |
| Lilly USA, LLC | 11 | $252 |
| Axsome Therapeutics, Inc. | 4 | $245 |
| Novo Nordisk Inc | 11 | $209 |
| Hologic Sales and Service, LLC | 1 | $19 |
Products named: Auvelity, Veozah, MOUNJARO, ZEPBOUND, Ozempic, Wegovy, Rybelsus, Saxenda.
Industry payments across MS — which companies pay providers there.
